About Pharmaoffer
Pharmaoffer is a Dutch B2B marketplace founded in 2018 that connects buyers and suppliers of pharmaceutical ingredients — primarily active pharmaceutical ingredients (APIs), excipients, and intermediates. The platform was built specifically to address a gap in the pharmaceutical sourcing market: horizontal B2B marketplaces list pharma suppliers without requiring the documentation that pharma buyers actually need, while regulatory databases provide documentation but no transaction infrastructure.
The platform is headquartered in Amsterdam and operates globally, with the largest supplier concentrations in India, China, and Europe. Around 2,400 supplier listings are active at the time of this review, with the catalogue weighted toward APIs over excipients. Buyers can search by product, INN name, therapeutic class, or supplier — and contact suppliers directly through the platform without intermediary fees.
Where Pharmaoffer differs from competitors is the verification floor: every supplier must provide GMP documentation as a condition of listing. That filter alone removes much of the noise that affects API sourcing on general B2B platforms.
How procurement teams use it
Pharmaoffer is primarily used in the early discovery and shortlisting phase of pharma sourcing — before deeper regulatory qualification, audits, or commercial conversations. Procurement teams we've spoken with use it for three workflows:
- Initial supplier discovery for a specific API or excipient, especially when sourcing a molecule for the first time or expanding geography on an existing molecule
- Alternative supplier identification for risk mitigation — finding second or third sources for ingredients already supplied by an incumbent
- Cross-border price benchmarking by collecting inquiries from suppliers in different regions before negotiating with the preferred vendor
It is not a tool for late-stage qualification — that work happens through regulatory verification, document checks, and on-site audits regardless of where the supplier was discovered. Pharmaoffer's job is to narrow the universe; the buyer's job is to qualify what remains.
What you'll find on the platform
The catalogue is structured around three categories. Active pharmaceutical ingredients form the largest segment, with product listings searchable by INN, therapeutic class, dosage form, or regulatory market authorisation. Excipients form a smaller but growing segment — including pharmaceutical-grade fillers, binders, and coating materials. Intermediates round out the catalogue for buyers sourcing earlier in the synthesis chain.
Each supplier listing includes a company profile, regulatory documentation references (GMP issuing authority, certificate validity), and category-level product catalogue. Buyers send inquiries through the platform, and supplier replies come directly from the supplier's own commercial team.
Pharmaoffer does not provide DMF filings, CEP regulatory data, or the structured supplier-intelligence layer that platforms like PharmaCompass offer. That's by design — the platform is for sourcing, not for regulatory due diligence. Most procurement teams use both in tandem.
Verification & trust signals
Pharmaoffer's verification framework operates at the listing level. Suppliers must submit GMP certification documentation issued by a recognised regulatory authority before they can list. The platform checks document validity and currency. That places Pharmaoffer in our Verified suppliers category — meaningful platform-level vetting applied across all listings, not gated behind premium tiers.
What the platform checks (and doesn't)
The honest read: Pharmaoffer's GMP requirement is a meaningful filter, not a guarantee. A GMP certificate from a credible authority is materially stronger than self-declaration, but it's a document check — not a physical audit. For orders above a threshold (we'd suggest $25,000), independent regulatory verification with the issuing authority and a fresh Certificate of Analysis remain essential before commercial commitment.
Fee model & economics
Pharmaoffer's fee structure is asymmetric — free for buyers, tiered for suppliers — which is standard for B2B marketplaces in this space. The platform earns from supplier listing tiers rather than transaction commissions, which means the platform's incentive is to attract suppliers rather than to mediate or take a cut of deals.
Browse suppliers, view product listings, and send up to a reasonable inquiry volume without paid access. No transaction commissions.
Registration unlocks inquiry history and saved searches but isn't required for one-off sourcing work.
Basic listing — free, with limits on product count, inquiry access, and profile depth.
Paid tiers — increasing access to inquiry leads, enhanced visibility, and featured placements. Pricing is per supplier per year, not per transaction.
The buyer-side economics are straightforward. The supplier-side calculation depends on the volume and quality of inquiries received — for an established API manufacturer targeting cross-border buyers, a paid tier typically earns back its cost from one or two qualified leads per year. For a smaller manufacturer, the basic free tier is the right starting point.
Field test results
We sent six test sourcing inquiries through Pharmaoffer during the most recent review cycle — three for high-volume APIs (paracetamol, atorvastatin, metformin) and three for lower-volume specialty ingredients. Response data below.
Response quality was meaningfully higher than the field test averages we see across horizontal B2B marketplaces. Of the six inquiries, five received substantive technical replies — pricing range, MOQ, lead time, and at minimum a willingness to share documentation. The sixth was a high-volume commodity API where one supplier sent a brochure rather than a quote; not great, but not unusual either.
The two suppliers who didn't send Certificates of Analysis on request both indicated they would share them after a signed NDA — a reasonable position for a first contact with an unknown buyer.
Should suppliers list on Pharmaoffer?
The supplier-side decision is more nuanced than the buyer-side recommendation. Pharmaoffer's buyer base is concentrated in pharma-specific sourcing, which means inquiries are higher-quality and lower-volume than what you'd see on horizontal B2B platforms — fewer tyre-kickers, more serious procurement professionals. For the right manufacturer, that's a meaningful trade.
- Best suited for suppliers with verified GMP credentials and capacity to serve cross-border buyers — the documentation requirement filters out unqualified buyers as well as suppliers
- Strongest fit for mid-sized API manufacturers in India and China who want exposure to European and North American buyers without dedicated business development
- Less useful for suppliers focused entirely on domestic markets — buyer activity is heavily cross-border
- Free tier is genuinely usable for initial testing; paid tiers earn out at one or two qualified leads per year for established manufacturers